ATHEROSCLEROSIS

 

Cardiovascular Effects of Cannabis                     (news – undated)

http://www.idmu.co.uk/canncardio.htm

 

Cannabinoids impair the formation of cholesteryl ester in cultured human cells. (full – 1981)                                           http://atvb.ahajournals.org/cgi/reprint/1/6/449

 

Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice. (full – 2005)                                           http://www.nature.com/nature/journal/v434/n7034/full/nature03389.html

 

Cannabis compound tackles blood vessel disease                    (news – 2005)

http://www.medicalnewstoday.com/articles/22658.php

 

Medical marijuana: study shows that THC slows atherosclerosis                      (news – 2005)

http://thenexthurrah.typepad.com/the_next_hurrah/2005/04/medical_marijua.html

 

Science: THC slows development of atherosclerosis in animal study                         (news – 2005)

http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=190#1

 

 

NOT SO DOPEY           (news – 2005)         http://www.entheology.org/edoto/anmviewer.asp?a=221

 

Marijuana Chemical Fights Hardened Arteries                (news – 2005)

http://www.webmd.com/heart-disease/news/20050406/marijuana-chemical-fights-hardened-arteries

 

Does Cannabis Hold the Key to Treating Cardiometabolic Disease              (full – 2006)

http://www.nature.com/nrcardio/journal/v3/n3/full/ncpcardio0504.html

 

Cannabinoid receptors in atherosclerosis.                 (abst – 2006)

http://www.ncbi.nlm.nih.gov/pubmed/16960500

 

Towards a therapeutic use of selective CB2 cannabinoid receptor ligands for atherosclerosis.        (abst – 2006)                                        http://www.ncbi.nlm.nih.gov/pubmed/19804131

 

The Cannabinergic System as a Target for Anti-inflammatory Therapies                (abst – 2006)

http://www.ingentaconnect.com/content/ben/ctmc/2006/00000006/00000013/art00008

 

Endocannabinoids and the haematological system             (full – 2007)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190025/?tool=pmcentrez

 

Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption         (full – 2007)  http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2228254&tool=pmcentrez

 

Decreased age-related cardiac dysfunction, myocardial nitrative stress, inflammatory gene expression, and apoptosis in mice lacking fatty acid amide hydrolase.                                                              (full – 2007)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2225473/?tool=pubmed

 

Cannabinoids and cardiovascular disease: the outlook for clinical treatments. (abst – 2007)

http://www.ncbi.nlm.nih.gov/pubmed/17627561?ordinalpos=1&itool=PPMCLayout.PPMCAppController.   PPMCArticlePage.PPMCPubmedRA&linkpos=5

 

Cannabinoid receptors in acute and chronic complications of atherosclerosis (full – 2008)                                     http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219535/?tool=pmcentrez

 

Pleiotropic effects of the CB2 cannabinoid receptor activation on human monocyte migration: implications for atherosclerosis and inflammatory diseases                                                          (full – 2008)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2267750/?tool=pubmed

 

CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways.                                                             (full – 2008)  http://ajpheart.physiology.org/content/294/3/H1145.long

 

Cholesterol-induced stimulation of platelet aggregation is prevented by a hempseed- enriched diet.         (abst – 2008)                           http://www.ncbi.nlm.nih.gov/pubmed/18418423

 

The emerging role of the endocannabinoid system in cardiovascular disease (full – 2009)                                   http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2791499/?tool=pmcentrez

 

Endocannabinoids and the Heart               (full – 2009)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2728560/?tool=pmcentrez

 

CB1 and CB2 cannabinoid receptors differentially regulate the production of reactive oxygen species by macrophages                                               (full – 2009)  http://cardiovascres.oxfordjournals.org/content/84/3/378.full?sid=7d2438c4-a727-410f-870d-  4a971695b4fb

 

Cannabidiol-2′,6′-Dimethyl Ether, a Cannabidiol Derivative, Is a Highly Potent and Selective 15-Lipoxygenase Inhibitor.                                                           (abst – 2009)  http://www.unboundmedicine.com/medline/ebm/record/19406952/abstract/Cannabidiol_2%276%27_Dime thyl_Ether_a_Cannabidiol_Derivative_Is_a_Highly_Potent_and_Selective_15_Lipoxygenase_Inhibitor_

 

Cannabinoids and atherosclerosis.                 (abst – 2009)  http://www.unboundmedicine.com/medline/ebm/record/19591373/abstract/Cannabinoids_and_atherosclero  sis_

 

Medical Marijuana and Arteriosclerotic Heart Disease                 (news – 2009)

https://www.marijuanadoctors.com/content/ailments/view/125?ailment=arteriosclerotic-heart-disease

 

US Patent Application 20100158973 – THERAPEUTIC USES OF CANNABIDIOL

COMPOUNDS           (full – 2010)     http://www.patentstorm.us/applications/20100158973/fulltext.html

 

WIN55212-2 ameliorates atherosclerosis associated with suppression of pro- inflammatory responses in ApoE-knockout mice.                                                                       (abst – 2010)  http://www.ncbi.nlm.nih.gov/pubmed/20868672

 

The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques                                         (full – 2011)  http://eurheartj.oxfordjournals.org/content/33/7/846.full

 

Cannabinoid receptor 2 signaling does not modulate atherogenesis in mice            (full – 2011)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082575/?tool=pubmed

 

Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full – 2011)                                  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/

 

Cannabinoid Receptor 2 Deficiency in Haematopoietic cells Aggravates Early Atherosclerosis in LDL Receptor Deficient Mice.                                                                      (full – 2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109635/?tool=pubmed

 

Atheroprotection via cannabinoid receptor-2 is mediated by circulating and vascular cells in vivo.           (abst – 2011)                 http://www.ncbi.nlm.nih.gov/pubmed/21884703

 

The effect of dietary hempseed on atherogenesis and contractile function in aortae from hypercholesterolemic rabbits.                                                           (abst – 2011)  http://www.ncbi.nlm.nih.gov/pubmed/21893466

 

Cannabinoids and atherosclerotic coronary heart disease.                    (full – 2012)

http://onlinelibrary.wiley.com/doi/10.1002/clc.21962/pdf

 

Antihyperglycemic and hypolipidemic effects of α, β-amyrin, a triterpenoid mixture from Protium heptaphyllum in mice                                                            (full – 2012)       http://www.lipidworld.com/content/11/1/98

 

Targeting cannabinoid receptor CB(2 ) in cardiovascular disorders: promises and controversies.   (full – 2012)

http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02042.x/full

 

The potential use of cannabidiol in the therapy of metabolic syndrome                    (abst – 2012)

http://www.ncbi.nlm.nih.gov/pubmed/22430005

 

Update on the endocannabinoid-mediated regulation of gelatinase release in arterial wall physiology and atherosclerotic pathophysiology.                                                (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/23253273

 

Share a link for